Isturisa (osilodrostat) for the Treatment of Cushing’s Disease

Isturisa® (osilodrostat) is the first 11-beta‐hyrdoxylase enzyme inhibitor indicated to treat Cushing’s disease in adult patients, who are ineligible or failed pituitary surgery. Credit: US National Library of Medicine, National Institutes of Health, Health & Human Services.



  • Isturisa®
  • Isturisa
  • Isturisa